Correlation Between Moderna and A1LN34
Can any of the company-specific risk be diversified away by investing in both Moderna and A1LN34 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moderna and A1LN34 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moderna and A1LN34, you can compare the effects of market volatilities on Moderna and A1LN34 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moderna with a short position of A1LN34. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moderna and A1LN34.
Diversification Opportunities for Moderna and A1LN34
Modest diversification
The 3 months correlation between Moderna and A1LN34 is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Moderna and A1LN34 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on A1LN34 and Moderna is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moderna are associated (or correlated) with A1LN34. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of A1LN34 has no effect on the direction of Moderna i.e., Moderna and A1LN34 go up and down completely randomly.
Pair Corralation between Moderna and A1LN34
Assuming the 90 days trading horizon Moderna is expected to under-perform the A1LN34. In addition to that, Moderna is 1.3 times more volatile than A1LN34. It trades about -0.15 of its total potential returns per unit of risk. A1LN34 is currently generating about 0.01 per unit of volatility. If you would invest 7,399 in A1LN34 on September 24, 2024 and sell it today you would lose (49.00) from holding A1LN34 or give up 0.66% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Moderna vs. A1LN34
Performance |
Timeline |
Moderna |
A1LN34 |
Moderna and A1LN34 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Moderna and A1LN34
The main advantage of trading using opposite Moderna and A1LN34 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moderna position performs unexpectedly, A1LN34 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in A1LN34 will offset losses from the drop in A1LN34's long position.Moderna vs. Novo Nordisk AS | Moderna vs. Vertex Pharmaceuticals Incorporated | Moderna vs. BIONTECH SE DRN | Moderna vs. BeiGene |
A1LN34 vs. Novo Nordisk AS | A1LN34 vs. Vertex Pharmaceuticals Incorporated | A1LN34 vs. Moderna | A1LN34 vs. BIONTECH SE DRN |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |